2019
DOI: 10.1097/01.hs9.0000561168.46160.37
|View full text |Cite
|
Sign up to set email alerts
|

Pf721 minimal Clinically Important Difference and Responsiveness for Hm‐pro in Patients With Haematological Malignancies

Abstract: overall survival (OS) in this cohort and for the subgroup of patients who fail to respond to the first CT. Results: A total of 36 EBV + PTLD pts were identified with a median follow up time of 23.4 months (mos) from the date of PTLD diagnosis. Median age at PTLD diagnosis was 47.5 years (yrs) (range 18-75); median time to PTLD onset from transplant was 2.4 yrs (range 0.2-28). Of these, 6 (16.7%) were polymorphic, 22 were diffuse large B cell lymphoma (61.1%), 3 were Burkitt lymphoma (8.3%), and other types 5 (… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles